Published in N Engl J Med on August 11, 2005
Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. J Clin Microbiol (2008) 2.10
The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS (2009) 1.37
Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting. Clin Infect Dis (2011) 1.28
How can we better identify early HIV infections? Curr Opin HIV AIDS (2015) 1.18
Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One (2013) 1.07
Routine laboratory screening for acute and recent HIV infection in Lima, Peru. Sex Transm Infect (2010) 0.86
Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection in Seoul, South Korea. Scand J Infect Dis (2013) 0.82
Clinical and public health implications of acute and early HIV detection and treatment: a scoping review. J Int AIDS Soc (2017) 0.77
Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM. J Clin Virol (2016) 0.77
Differences in Risk Behavior and Demographic Factors between Men who have Sex with Men with Acute and Non-Acute Human Immunodeficiency Virus Infection in a Community-Based Testing Program in Los Angeles. J Acquir Immune Defic Syndr (2016) 0.75
Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60
Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med (2012) 6.29
Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health (2002) 6.01
Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr (2008) 5.05
Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS (2004) 4.64
Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA (2005) 4.32
Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis (2005) 4.27
Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS (2004) 4.17
Public health. Reassessing HIV prevention. Science (2008) 4.06
Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med (2004) 3.54
"Street medicine": Collaborating with a faith-based organization to screen at-risk youths for sexually transmitted diseases. Am J Public Health (2004) 3.53
Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis (2005) 3.28
SEXINFO: a sexual health text messaging service for San Francisco youth. Am J Public Health (2008) 3.16
Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr (2010) 2.79
Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS (2006) 2.72
High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS (2003) 2.65
Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am J Med (2005) 2.59
Male circumcision for protection against HIV infection in sub-Saharan Africa: the evidence in favour justifies the implementation now in progress. Glob Public Health (2015) 2.56
Syphilis and HIV infection: an update. Clin Infect Dis (2007) 2.55
Trends in the diagnosis and treatment of ectopic pregnancy in the United States. Obstet Gynecol (2010) 2.50
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J Antimicrob Chemother (2010) 2.41
The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis (2013) 2.39
Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis (2008) 2.33
Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007. PLoS One (2008) 2.32
Association between rates of HIV testing and elimination of written consents in San Francisco. JAMA (2007) 2.32
Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999-2001, USA. Am J Public Health (2002) 2.30
Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS (2005) 2.22
Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol (2009) 2.18
Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr (2006) 2.15
Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis (2006) 2.10
Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. Sex Transm Dis (2005) 2.08
Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Clin Infect Dis (2006) 2.06
California guidelines for expedited partner therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis (2008) 2.03
Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men. Clin Infect Dis (2009) 2.02
Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003. Clin Infect Dis (2005) 2.01
HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2002) 1.94
Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA (2006) 1.90
Differential persistence of transmitted HIV-1 drug resistance mutation classes. J Infect Dis (2011) 1.90
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia. AIDS (2002) 1.87
The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother (2009) 1.80
Utilization of health services in physician offices and outpatient clinics by adolescents and young women in the United States: implications for improving access to reproductive health services. J Adolesc Health (2009) 1.76
Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection. J Infect Dis (2005) 1.76
Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J Virol (2002) 1.74
Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System. J Clin Microbiol (2003) 1.73
Relating HIV-1 sequence variation to replication capacity via trees and forests. Stat Appl Genet Mol Biol (2004) 1.73
Drug resistance mutations in HIV-1. Top HIV Med (2003) 1.72
Men who have sex with men and transgenders in Mumbai, India: an emerging risk group for STIs and HIV. Indian J Dermatol Venereol Leprol (2006) 1.69
HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005. J Acquir Immune Defic Syndr (2008) 1.68
Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem (2006) 1.68
Real-time quantitation of HIV-1 p24 and SIV p27 using fluorescence-linked antigen quantification assays. AIDS (2003) 1.66
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin Infect Dis (2005) 1.64
Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests. J Clin Microbiol (2009) 1.61
The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2. Sex Transm Dis (2004) 1.61
Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr (2013) 1.57
Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis (2003) 1.56
HIV testing frequency among men who have sex with men attending sexually transmitted disease clinics: implications for HIV prevention and surveillance. J Acquir Immune Defic Syndr (2009) 1.55
The epidemiology of herpes simplex virus type 2 infection in low-income urban populations in coastal Peru. Sex Transm Dis (2005) 1.54
Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS (2004) 1.53
Chlamydia and gonorrhea screening in San Francisco high schools. Sex Transm Dis (2002) 1.53
Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis (2001) 1.52
Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection. Mayo Clin Proc (2007) 1.52
Clients of female sex workers in Lima, Peru: a bridge population for sexually transmitted disease/HIV transmission? Sex Transm Dis (2004) 1.52
Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis. J Infect Dis (2010) 1.51
The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis (2011) 1.50
Household effects of school closure during pandemic (H1N1) 2009, Pennsylvania, USA. Emerg Infect Dis (2010) 1.49
Cephalosporin resistance in Neisseria gonorrhoeae infections. JAMA (2013) 1.47
Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother (2009) 1.47
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. J Virol (2006) 1.47
CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy. J Infect Dis (2002) 1.46
Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. AIDS Care (2009) 1.45
Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment. AIDS Behav (2012) 1.44
Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa. J Int AIDS Soc (2011) 1.42
inSPOT: the first online STD partner notification system using electronic postcards. PLoS Med (2008) 1.42
Field-delivered therapy increases treatment for chlamydia and gonorrhea. Am J Public Health (2003) 1.41
Longer hospital stay is associated with higher rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan Africa. BMC Infect Dis (2014) 1.41
Randomized, controlled trial of therapy interruption in chronic HIV-1 infection. PLoS Med (2004) 1.41
Internet-based health promotion and disease control in the 8 cities: successes, barriers, and future plans. Sex Transm Dis (2005) 1.41
The impact of STIs. MLO Med Lab Obs (2006) 1.40
Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis (2007) 1.40
Access to care issues for African American communities: implications for STD disparities. Sex Transm Dis (2008) 1.39
Acceptability of male circumcision among mothers with male children in Mysore, India. AIDS (2008) 1.39
Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009. PLoS One (2010) 1.39
Diagnostic tests for common STDs and HSV-2. MLO Med Lab Obs (2004) 1.39
A 'snip' in time: what is the best age to circumcise? BMC Pediatr (2012) 1.36
Routine detection of acute HIV infection through RNA pooling: survey of current practice in the United States. Sex Transm Dis (2007) 1.36
The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study. PLoS Med (2012) 1.35
Effect of a brief video intervention on incident infection among patients attending sexually transmitted disease clinics. PLoS Med (2008) 1.35
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS (2014) 1.34
Partner notification for sexually transmitted diseases in Peru: knowledge, attitudes, and practices in a high-risk community. Sex Transm Dis (2007) 1.33
Prevalence of same-sex sexual behavior and associated characteristics among low-income urban males in Peru. PLoS One (2007) 1.31
Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health (2009) 1.29
Chemoprophylaxis of HIV infection: moving forward with caution. J Infect Dis (2006) 1.28
High rates of sex with men among high-risk, heterosexually-identified men in low-income, coastal Peru. AIDS Behav (2007) 1.28
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection. J Infect Dis (2004) 1.27
New populations at high risk of HIV/STIs in low-income, urban coastal Peru. AIDS Behav (2007) 1.27